No.8 How to Design the Artificial Polymer that may suck up amyloid-β

2023.3.15

アバターを使ったビデオ・チュートリアル・トップページ

概要：

Lecanemab, developed by the Japanese pharmaceutical company Eisai, may be said to dissolve amyloid-β well. If we can get the Hansen Solubility Parameters (HSP) of the central nervous system, we can design a polymer that is close to the HSP, which is easy with HSPiP. I also wrote a blog. What kind of brain can remember the structure of an Alzheimer’s drug? https://www.pirika.com/wp/en/archives/1438